- Goodnick PJ, Goldstein BJ (1998) SSRIs in affective disorders-I. Basic pharmacology, J Psychopharmacol 12 (suppl B): S5-S20.
- Bolden-Watson C, Richelson E ( 1993) Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sei 52: 1023-9.
- Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related com-pounds at human monoamine transporters. Ear J Pharmacol 340: 249-58.
- Narita N, Hashimoto K, Tomitaka S et al (1996) Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol 307: 117-9.
- Sanchez C, Meier E ( 1997) Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Psycho-phamwcol 29: 197-205.
- Bastianetto S, Perrault G, Sanger DJ (1995) Pharmacological evidence of the involvement of sigma sites in DTG-induced contralateral circling in rats. Ncumpharmacol 34: 107-14.
- Bergeron R, Debonnel G, De Montigny C (1993) Modification of the N-methyl-D-aspartate response by antidepressant s receptor ligands. Eur J Pharmacol 240: 319-23.
- Wong DTY, Threlkeld PG, Robertson DW (1991) Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors. Neuropsychophar-macol 5: 43-7.
- Jenck F, MoreauJ-L, Mutel V et al (1993) Evidence for a role of 5-HTle receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231: 223-9.
- Wood MD, Glen A, Blackburn TP et al ( 1993) Fluoxetine has high affinity for the cloned rat and human 5-HTu receptor and the human 5-HT2 receptor. BrJ Pharmacol 110 (Proc. Suppl.) 102P.
- Syvalahti EKG, Laakso A, Pahinaki E-P et al (1995) Up- regulation of 5-HT2e receptors by citalopram and fluoxetine in rat brain. Eur Neumpsychoparmacol 5 (suppl 3): 291.
- Palvimaki E-P, Roth BL, Majasuo H et al (1996) Interactions of selective serotonin reuptake inhibitors with the serotonin 5HT2e receptor. Psychoparmacology126: 234-40.
- Tollefson GD, Sayler ME (1997) Course of psychomotor agitation during pharmacotherapy of depression: analysts from double-blind controlled trials with fluoxetine. Depression Anxiety 4: 294-311.
- Mendels J (1992) The acute and long-term treatment of major depression, int CIin Psychopharmacol 7 (suppl 2): 21-30.
- Beasley CM, Sayler ME, Bosomworth JC, Wernicke JF (1991) High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression. J Clin Psychopharmacol 11: 166-74.
- Sechter D, Troy S, Paternetti S, Boyer P (1999) A double-blind comparison of sertraline and fluoxetine in the treatment of major depression in outpatients. Eur Psychiatry 14: 1-64.
- Small GW, Hamilton HH, Bystritsky A et al and the Fluoxetine Collaborative Study Group (1995) Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Int Psychogeriatrics 7 (suppl): 4153.
- . Bennie EH, Mullin JM, Mariindale JJ (1995) A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression. J Clin Psychiatry 56: 229-37.
- Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
- Hamilton M ( 1967) Development of a rating scale for primary depressive illness. BrJ Soc Clin Psychol 6: 278-96.
- Guy W (1976) (revised 1991) ECDEU Assessment Manual for Psychopharmacology (revised) US Dept Health, Education, and Welfare publication (ADM) 91-338. National Institute of Mental Health, Rockville, MD.
- Hamilton M (1959) The assessment of anxiety states by rating. BrJ Metd Psychol 32: 50-5.
- Hamilton M (1969) Diagnosis and rating of anxiety. In: Studies of Anxiety (ed MII Lader) BrJ Psychiatry 3 (spec pub): 76-9.
- Raskin A, Schulterbrandt J, Reatig N et al (1969) Replication of factors of psychopathology in interview, ward behaviour and self report ratings of hospitalized depressives. J Nerv Ment Dis 148: 87-98.
- Lipman RS, Covi L (1976) Outpatient treatment of neurotic depression: medication and group psychotherapy. In: Evalua-tion of Psychological Therapies (eels R Spitzer, D Klein) 178-218. Johns Hopkins University Press, Baltimore, MD.
- Parrot AC, Hindmarch I (1978) Factor analysis of a sleep evaluation questionnaire. Psychol Med 8: 325-9.
- Clean' P, Guy W (1975) Factor analysis of the Hamilton Depression Scale.(Presented at the International Symposium on the Evaluation of New Drugs in Clinical Psychopharmacology, Pisa, September).
- Buchwald AM, Rudick-Davis D (1993) The symptoms of major depression.J Abnorm Psychol 192: 197-205.
- Parker G, Brotchie H (1992) Psychomotor change as a feature of depressive disorders: an historical overview. Aust NZ J Psychiatry 27: 56-61.
- Parker G, Hadzi-Pavlovic D, Boyce P (1996) Issues in classification: 11. Classifying melancholia. In: Melancholia (eds GD Parker, D Hadzi-Pavlovic) 20- 37.Cambridge University Press, Cambridge.
- DeClerc GE, Ruimy P, Verdeau-Pailles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospita-lized for major depression and melancholia. Int Clin Psycho-pharmacol 9: 138-43.
- Bondareff W, Alpert M, Friedhoff AJ et al (2000) Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. AmJ Psychiatry 157: 729-36.
International Journal of Psychiatry in Clinical Practice
Volume 5, 2001 - Issue 2